Joseph Shelton MD

Department of Radiation Oncology
Associate Professor

(404) 616-6343
jwshelt@emory.edu

Overview

Dr. Shelton is a board certified radiation oncologist specializing in the treatment of kidney cancer, lung cancer, prostate cancer, testicular cancer, and uterine cancer. He treats patients at Loughlin Radiation Oncology Center at Grady, where he serves as medical director.

Dr. Shelton received his MD from the University of North Carolina. He did his internship at the Emory University School of Medicine and completed his residency at the Department of Radiation Oncology, Emory University School of Medicine.

Academic Appointment

Associate Professor, Department of Radiation Oncology, Emory University School of Medicine

Education

Degrees

MD from University of North Carolina
BS from University of Virginia

Research

Focus

The treatment and outcomes of patients with gynecologic and genitourinary malignancies. Current work focuses on development of new treatment strategies combining modern radiotherapy and chemotherapy in post-cystectomy bladder cancer patients. Other work involves investigating strategies for adapting brachytherapy and external beam radiation treatments to improving outcomes in cervical cancer patients.

Publications

Data-Driven Volumetric Computed Tomography Image Generation From Surface Structures Using a Patient-Specific Deep Leaning Model.
Int J Radiat Oncol Biol Phys Volume: 121 Page(s): 1349 - 1360
04/01/2025 Authors: Pan S; Chang C-W; Tian Z; Wang T; Axente M; Shelton J; Liu T; Roper J; Yang X
Improving Lung Stereotactic Body Radiation Therapy Dose Conformity Using a Simple Noncoplanar Volumetric Modulated Arc Therapy Technique.
Pract Radiat Oncol
02/25/2025 Authors: Kei T; Luca K; Kayode O; Higgins KA; Bradley JD; Shelton JW; Patel AB; Yang X; Schreibmann E; Zhang J
Characteristics, Treatment, and Outcomes of Primary Urethral Cancer: A Multicenter Review Over Two Decades.
Clin Genitourin Cancer Volume: 23 Page(s): 102276
02/01/2025 Authors: Hopkins BD; Qian DC; Xu KM; McCook-Veal A; Switchenko J; Hartsell LM; Cimmino CB; Joshi SS; Narayan V; Master VA
The Use of External Beam Radiation Therapy for Heterotopic Ossification Prophylaxis After Surgical Fixation of Acetabular Fractures: A Randomized Controlled Trial.
J Orthop Trauma Volume: 39 Page(s): e9 - e13
02/01/2025 Authors: Boissonneault A; O'Hara NN; Slobogean GP; Meyer A; Maceroli M; Sciadini MF; Nascone JW; Gage MJ; Lin J; Hanasoge S
Using a patient-specific diffusion model to generate CBCT-based synthetic CTs for CBCT-guided adaptive radiotherapy.
Med Phys Volume: 52 Page(s): 471 - 480
01/01/2025 Authors: Chen X; Qiu RLJ; Wang T; Chang C-W; Chen X; Shelton JW; Kesarwala AH; Yang X
CBCT-based synthetic CT image generation using a diffusion model for CBCT-guided lung radiotherapy.
Med Phys Volume: 51 Page(s): 8168 - 8178
11/01/2024 Authors: Chen X; Qiu RLJ; Peng J; Shelton JW; Chang C-W; Yang X; Kesarwala AH
Tailoring language for genitourinary function in patients with newly diagnosed prostate cancer to facilitate discussions in diverse populations and overcome health literacy barriers.
Cancer Volume: 130 Suppl 20 Page(s): 3602 - 3611
10/15/2024 Authors: Kilbridge KL; Patil D; Filson CP; Shelton JW; Thomson SW; Rosenbaum CH; Rothmann EC; Martin-Doyle W; Trinh Q-D; Narayan VM
Impact of Rectal Spacer on Toxicity Reduction in Men Treated With Proton Versus Photon Therapy.
Int J Part Ther Volume: 13 Page(s): 100111
09/01/2024 Authors: Dhere VR; Goyal S; Zhou J; Sebastian NT; Patel AB; Hanasoge S; Patel PR; Shelton J; Godette KD; Hershatter BW
Impact of androgen deprivation therapy in patients with unfavorable intermediate-risk prostate cancer receiving brachytherapy-based dose-escalated radiation therapy.
J Contemp Brachytherapy Volume: 16 Page(s): 268 - 272
08/01/2024 Authors: Sebastian NT; Goyal S; Liu Y; Dhere V; Jani AB; Hershatter B; Patel PR; Shelton JW; Hanasoge S; Godette KD
MRI-based prostate cancer classification using 3D efficient capsule network.
Med Phys Volume: 51 Page(s): 4748 - 4758
07/01/2024 Authors: Li Y; Wynne J; Wang J; Roper J; Chang C-W; Patel AB; Shelton J; Liu T; Mao H; Yang X
Patterns of Undertreatment and Overtreatment in Adjuvant Radiotherapy for Early-Stage Endometrial Cancer Based on Molecular Classification.
JAMA Oncol Volume: 10 Page(s): 671 - 674
05/01/2024 Authors: Ciobanu O; He Y; Martin AR; Remick JS; Shelton JW; Eng TY; Qian DC
Implementation of a Novel Chart Rounds Application to Facilitate Peer Review in a Virtual Academic Environment.
Adv Radiat Oncol Volume: 9 Page(s): 101406
03/01/2024 Authors: Ali N; Schreibmann E; Kayode O; Patel A; Patel P; Qian D; McCall N; Lorenz J; Higgins KA; Bradley J
Biochemical Relapse-Free Survival in Postprostatectomy Patients Receiving 18F-Fluciclovine-Guided Prostate Bed-Only Radiation: Post Hoc Analysis of a Prospective Randomized Trial.
Volume: 14 Page(s): e492 - e499
01/01/2024 Authors: Dhere VR; Schuster DM; Goyal S; Schreibmann E; Hershatter BW; Patel SA; Shelton JW; Hanasoge S; Patel PR; Sebastian NT
Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non-small cell lung cancer.
Cancer Volume: 129 Page(s): 3713 - 3723
12/01/2023 Authors: McCall NS; Janopaul-Naylor JR; McGinnis HS; Kesarwala AH; Tian S; Stokes WA; Shelton JW; Steuer CE; Carlisle JW; Leal TA
Associations of the gut microbiome with psychoneurological symptom cluster in women with gynecologic cancers: a longitudinal study.
Support Care Cancer Volume: 31 Page(s): 626
10/11/2023 Authors: Barandouzi ZA; Eng T; Shelton J; Khanna N; Scott I; Meador R; Bruner DW
Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy.
JAMA Netw Open Volume: 6 Page(s): e2327637
08/01/2023 Authors: Sebastian N; Goyal S; Liu Y; Janopaul-Naylor JR; Patel PR; Dhere VR; Hanasoge S; Shelton JW; Godette KD; Jani AB
2D medical image synthesis using transformer-based denoising diffusion probabilistic model.
Phys Med Biol Volume: 68
05/05/2023 Authors: Pan S; Wang T; Qiu RLJ; Axente M; Chang C-W; Peng J; Patel AB; Shelton J; Patel SA; Roper J
Data-Driven Volumetric Image Generation from Surface Structures using a Patient-Specific Deep Leaning Model.

05/02/2023 Authors: Pan S; Chang C-W; Axente M; Wang T; Shelton J; Liu T; Roper J; Yang X
Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial.
J Nucl Med Volume: 64 Page(s): 586 - 591
04/01/2023 Authors: Lawal IO; Jani AB; Adediran OA; Goyal S; Abiodun-Ojo OA; Dhere VR; Marcus CV; Joshi SS; Master VA; Patel PR
Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy.
Clin Nucl Med Volume: 48 Page(s): e153 - e159
04/01/2023 Authors: Lawal IO; Marcus C; Schuster DM; Goyal S; Adediran OA; Dhere VR; Joshi SS; Abiodun-Ojo OA; Master VA; Patel PR
RELATIONSHIP BETWEEN MULTI-LEVEL SOCIOECONOMIC STATUS AND QUALITY OF LIFE IN WOMEN WITH GYNECOLOGIC CANCERS: A LONGITUDINAL PILOT STUDY
Volume: 50
03/01/2023 Authors: Barandouzi ZA; Boitos DR; Eng T; Patel P; Shelton J; Khanna N; Scott I; Meador R; Bruner DW
Associations Between Social Determinants of Health and Psychoneurologic Symptom Clusters in Women With Gynecologic Cancers: A Longitudinal Study.
Oncol Nurs Forum Volume: 50 Page(s): 241 - 251
02/17/2023 Authors: Barandouzi ZA; Bai J; Eng TY; Patel P; Shelton J; Khanna N; Scott I; Remick J; Meador R; Watkins Bruner D
Incidence and predictors of toxicity in the management of vulvar squamous cell carcinoma treated with radiation therapy.
Gynecol Oncol Rep Volume: 44 Page(s): 101086
12/01/2022 Authors: McCall NS; Eng TY; Shelton JW; Hanasoge S; Patel PR; Patel AB; McCook-Veal AA; Switchenko JM; Cole TE; Khanna N
Impact of Radiation Dose to the Immune Cells in Unresectable or Stage III Non-Small Cell Lung Cancer in the Durvalumab Era
Volume: 17 Page(s): S109 - S109
09/01/2022 Authors: Mccall NS; McGinnis HS; Janopaul-Naylor JR; Kesarwala AH; Tian S; Stokes WA; Shelton JW; Steuer CE; Carlisle JW; Leal T
Phase I Study of Palliative Radiotherapy with Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer
Volume: 17 Page(s): S541 - S541
09/01/2022 Authors: Mccall NS; Switchenko JM; Tian S; Stokes WA; Kahn S; Kesarwala AH; Shelton JW; Szabo SM; Steuer CE; Carlisle JW
Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab era.
Radiother Oncol Volume: 174 Page(s): 133 - 140
09/01/2022 Authors: McCall NS; McGinnis HS; Janopaul-Naylor JR; Kesarwala AH; Tian S; Stokes WA; Shelton JW; Steuer CE; Carlisle JW; Leal T
Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (18F) Positron Emission Tomography/Computed Tomography-Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects.
Int J Radiat Oncol Biol Phys Volume: 113 Page(s): 1003 - 1014
08/01/2022 Authors: Dhere VR; Schuster DM; Goyal S; Schreibmann E; Hershatter BW; Rossi PJ; Shelton JW; Patel PR; Jani AB
Daily Coverage Assessment Using Deep Learning Generated Synthetic CT for Lung SBRT Patients
Volume: 49 Page(s): E730 - E731
06/01/2022 Authors: Qiu R; Lei Y; Shelton J; Higgins K; Bradley J; Curran W; Liu T; Kesarwala A; Yang X
Multi-Organ Segmentation On Female Pelvic CT Images Using Hierarchical Target Activation Network
Volume: 49 Page(s): E795 - E796
06/01/2022 Authors: Wang T; Lei Y; Roper J; Shelton J; Liu T; Yang X
Deep-Learning-Based Automated HDR Applicator Digitization for GYN Brachytherapy
Volume: 49 Page(s): E819 - E819
06/01/2022 Authors: Momin S; Lei Y; Wang T; Axente M; Roper J; Shelton J; Bradley J; Liu T; Yang X
Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era.
Front Oncol Volume: 12 Page(s): 1074675
01/01/2022 Authors: Janopaul-Naylor JR; Cao Y; McCall NS; Switchenko JM; Tian S; Chen H; Stokes WA; Kesarwala AH; McDonald MW; Shelton JW
Bone Marrow Suppression during Postoperative Radiation for Bladder Cancer and Comparative Benefit of Proton Therapy-Phase 2 Trial Secondary Analysis.
Int J Part Ther Volume: 8 Page(s): 1 - 10
01/01/2022 Authors: Press RH; Shelton JW; Zhang C; Dang Q; Tian S; Shu T; Seldon CS; Hasan S; Jani AB; Zhou J
Randomized Trial of Conventional vs Conventional Plus Fluciclovine (18F) PET/CT-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer: Volumetric and Patient-Reported Toxicity Analyses.
Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e271 - e272
11/01/2021 Authors: Dhere VR; Schuster DM; Goyal S; Schreibmann E; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Jani A
Clinical Outcomes and Assessment of Racial Disparities for Vulvar Squamous Cell Carcinoma Treated With Radiotherapy.
Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e637 - e638
11/01/2021 Authors: Remick JS; McCall NS; Khanna N; Shelton JW; Hanasoge S; Patel PR; Patel AB; Cole T; McCook A; Gordon AN
Severe Toxicity and Provider-Reported Subjective Symptoms in Patients With Vulvar Cancer Receiving Curative-Intent Radiotherapy.
Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e636
11/01/2021 Authors: McCall NS; Eng TY; Shelton JW; Hanasoge S; Patel PR; Patel AB; McCook A; Switchenko J; Cole T; Khanna N
Deep learning-based thoracic CBCT correction with histogram matching.
Biomed Phys Eng Express Volume: 7
10/29/2021 Authors: Qiu RLJ; Lei Y; Shelton J; Higgins K; Bradley JD; Curran WJ; Liu T; Kesarwala AH; Yang X
Lung Stereotactic Body Radiation Therapy for Treatment of Oligoprogressive and Oligorecurrent Metastatic Disease: A Multi-Center Analysis
Volume: 16 Page(s): S957 - S958
10/01/2021 Authors: Tian S; Kazzi B; Mccook A; Switchenko J; Stokes W; Shelton J; Kahn S; Carlisle J; Steuer C; Owonikoko T
Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database.
Clin Genitourin Cancer Volume: 19 Page(s): e193 - e199
08/01/2021 Authors: Xu KM; Liu Y; Gillespie TW; Osunkoya AO; Carthon B; Bilen MA; Filson CP; Ogan K; Patel PR; Shelton JW
Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy.
Clin Genitourin Cancer Volume: 19 Page(s): 255 - 266.e7
06/01/2021 Authors: Liu Y; Patel SA; Jani AB; Gillespie TW; Patel PR; Godette KD; Hershatter BW; Shelton JW; McDonald MW
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
Lancet Volume: 397 Page(s): 1895 - 1904
05/22/2021 Authors: Jani AB; Schreibmann E; Goyal S; Halkar R; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Xu KM; Goodman M
DEPRESSIVE SYMPTOMS AND PREDICTORS IN WOMEN WITH GYNECOLOGIC CANCER: A LONGITUDINAL ASSESSMENT
Volume: 48 Page(s): 72 - 72
03/01/2021 Authors: Barandouzi ZA; Eng T; Shelton J; Patel P; Khanna N; Bruner D
Comparisons of Depression, Sexual Function, and Quality of Life Between Women With Gynecological Cancers and Race-Matched Healthy Controls.
Cancer Nurs Volume: 44 Page(s): 116 - 124
03/01/2021 Authors: Bai J; Belcher SM; Meador R; Daniel G; Shelton J; Patel P; Dolan M; Arluck J; Khanna N; Horowitz I
Virtual Away Rotations Increase Access to Radiation Oncology.
Pract Radiat Oncol Volume: 11 Page(s): 325 - 327
01/01/2021 Authors: Janopaul-Naylor J; Qian D; Khan M; Brown S; Lin J; Syed Y; Schlafstein A; Ali N; Shelton J; Bradley J
Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database.
Clin Transl Radiat Oncol Volume: 26 Page(s): 30 - 34
01/01/2021 Authors: Janopaul-Naylor JR; Zhong J; Liu Y; Zhang C; Osunkoya AO; Joshi SS; Bilen MA; Carthon B; Kucuk O; Hartsell LM
Changes in the Vaginal Microbiome and Associated Toxicities Following Radiation Therapy for Gynecologic Cancers.
Front Cell Infect Microbiol Volume: 11 Page(s): 680038
01/01/2021 Authors: Tsementzi D; Meador R; Eng T; Patel P; Shelton J; Arluck J; Scott I; Dolan M; Khanna N; Konstantinidis KT
Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients With Localized, High-Risk Prostate Cancer.
Adv Radiat Oncol Volume: 6 Page(s): 100803
01/01/2021 Authors: McCall NS; Liu Y; Patel SA; Hershatter B; Moghanaki D; Godette KD; Hanasoge S; Patel P; Fischer-Valuck BW; Shelton JW
Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer.
Volume: 108 Page(s): 1397
12/01/2020 Authors: Jani A; Schreibmann E; Goyal S; Raghuveer H; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Xu KM; Goodman M
Analysis of Radiation Facility Volume and Survival in Men With Lymph Node-Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy.
JAMA Netw Open Volume: 3 Page(s): e2025143
12/01/2020 Authors: Patel SA; Goyal S; Liu Y; Moghanaki D; Patel PR; Hanasoge S; Dhere VR; Shelton JW; Godette KD; Jani AB
Bladder Preserving Chemoradiotherapy Compared To Surgery For Variants Of Urothelial Carcinoma And Tumors With Divergent Differentiation: An Analysis Of The National Cancer Database
Volume: 108 Page(s): E887 - E888
11/01/2020 Authors: Janopaul-Naylor J; Zhong J; Liu Y; Zhang C; Osunkoya AO; Joshi SS; Bilen MA; Carthon B; Kucuk O; Hartsell LM
Learning-based Real-time Patient-specific Volumetric Imaging for Lung Stereotactic Body Radiation Therapy
Volume: 108 Page(s): E345 - E346
11/01/2020 Authors: Yang X; Lei Y; Tian Z; Roper JR; Wang T; Higgins KA; Shelton JW; Bradley JD; Curran WJ; Liu T
4D CT Deformable Registration Using Unsupervised Deep Learning for Lung Stereotactic Body Radiation Therapy
Volume: 108 Page(s): E342 - E343
11/01/2020 Authors: Yang X; Fu Y; Lei Y; Tian Z; Wang T; Higgins KA; Shelton JW; Bradley JD; Curran WJ; Liu T
Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis.
Int J Radiat Oncol Biol Phys Volume: 108 Page(s): 304 - 313
09/01/2020 Authors: Tian S; Switchenko JM; Buchwald ZS; Patel PR; Shelton JW; Kahn SE; Pillai RN; Steuer CE; Owonikoko TK; Behera M
Vaginal microbiome associated with patient-reported sexual dysfunction and physician-reported vaginal adverse events in gynecologic cancer women across radiotherapy
Volume: 80
08/01/2020 Authors: Bai J; Tsementzi D; Patel P; Shelton J; Dolan M; Arluck J; Khanna N; Eng TY; Konstantinidis KT; Bruner DW
Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women.
Cancer Med Volume: 9 Page(s): 3714 - 3724
06/01/2020 Authors: Tsementzi D; Pena-Gonzalez A; Bai J; Hu Y-J; Patel P; Shelton J; Dolan M; Arluck J; Khanna N; Conrad L
Trajectories of sexual dysfunction and its risk factors in women with gynecologic cancer across radiation therapy and healthy controls.
Volume: 38
05/20/2020 Authors: Bai J; Tsementzi D; Patel PR; Shelton JW; Dolan M; Arluck J; Bruner D
18F-fluciclovine PET/CT findings are predictive of failure-free survival following salvage radiotherapy in post-prostatectomy patients with biochemical recurrence.
Volume: 61
05/01/2020 Authors: Abiodun-Ojo O; Jani A; Akintayo A; Alemozaffar M; Akin-Akintayo O; Tade F; Master V; Patel P; Shelton J; Kucuk O
Lung Stereotactic Body Radiotherapy and Concurrent Immunotherapy: A Multi-Center Safety and Toxicity Analysis
Volume: 14 Page(s): S248 - S248
10/01/2019 Authors: Tian S; Switchenko J; Patel P; Shelton J; Kahn S; Pillai R; Steuer C; Owonikoko T; Behera M; Curran W
Integration of Durvalumab into the Treatment of Stage III Non-Small Cell Lung Cancer: Real-World Considerations
Volume: 14 Page(s): S588 - S589
10/01/2019 Authors: Gorgens S; Schreibmann E; Behera M; Steuer C; Pillai R; Owonikoko T; Shelton J; Ramalingam S; Curran W; Higgins K
Overall Survival Following Treatment of Localized Prostate Cancer with Proton Therapy, External Beam Photon Therapy, or Brachytherapy: A National Cancer Data Base Analysis
Volume: 105 Page(s): E294 - E294
09/01/2019 Authors: Liu Y; Jani A; Gillespie T; Patel SA; Patel PR; Godette KD; Hershatter B; Shelton JW; McDonald MW
[F-18]-fluciclovine positivity rate is not affected by androgen deprivation therapy (ADT) in recurrent prostate cancer post-prostatectomy.
Volume: 60
05/01/2019 Authors: Abiodun-Ojo O; Jani A; Akintayo A; Alemozaffar M; Akin-Akintayo O; Odewole O; Tade F; Nieh P; Master V; Patel P
Design and Evaluation of a Semi-Automated Algorithm for Segmentation of Anti-[18F]FACBC (Fluciclovine F18) PET Images for Post-Prostatectomy Radiation Therapy
Volume: 102 Page(s): E561 - E561
11/01/2018 Authors: Schreibmann E; Schuster DM; Patel PR; Shelton JW; Cooper S; Raghuveer H; Jani A
Health care disparities among octogenarians and nonagenarians with stage III lung cancer.
Cancer Volume: 124 Page(s): 775 - 784
02/15/2018 Authors: Cassidy RJ; Zhang X; Switchenko JM; Patel PR; Shelton JW; Tian S; Nanda RH; Steuer CE; Pillai RN; Owonikoko TK
Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable, Stage III Non-Small Cell Lung Cancer: A Phase I Study
Volume: 12 Page(s): S2013 - S2014
11/01/2017 Authors: Higgins K; Pillai R; Chen Z; Zhang C; Patel P; Pakkala S; Shelton J; Force S; Fernandez F; Steuer C
Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.
J Thorac Oncol Volume: 12 Page(s): 1687 - 1695
11/01/2017 Authors: Higgins KA; Pillai RN; Chen Z; Tian S; Zhang C; Patel P; Pakkala S; Shelton J; Force SD; Fernandez FG
Next Generation Sequencing and Clinical Outcomes of Lung Adenocarcinomas Treated With Stereotactic Body Radiation Therapy
Volume: 99 Page(s): S241 - S241
10/01/2017 Authors: Cassidy RJ; Zhang X; Patel PR; Shelton JW; Escott CE; Sica GL; Rossi MR; Hill CE; Steuer C; Pillai R
Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.
Cancer Volume: 123 Page(s): 3681 - 3690
10/01/2017 Authors: Cassidy RJ; Zhang X; Patel PR; Shelton JW; Escott CE; Sica GL; Rossi MR; Hill CE; Steuer CE; Pillai RN
Impact of 18F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial.
J Nucl Med Volume: 58 Page(s): 412 - 418
03/01/2017 Authors: Jani AB; Schreibmann E; Rossi PJ; Shelton J; Godette K; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R
Clinical outcomes and the role of adjuvant therapy sequencing in Type II uterine cancer following definitive surgical treatment.
Eur J Gynaecol Oncol Volume: 38 Page(s): 404 - 412
01/01/2017 Authors: Heumann TR; Diaz R; Liu Y; Hanley K; Bang S; Horowitz IR; Khanna N; Shelton JW
Pretreatment Quality Assurance for Stereotactic Body Radiation Therapy (SBRT): Feasibility of Weekly "SBRT Rounds" in a High-Volume, Multicenter Academic Practice
Volume: 96 Page(s): E546 - E546
10/01/2016 Authors: Parks J; Esiashvili N; Patel PR; Shelton JW; Dhabaan AH; Elder E; Ghavidel S; Whitaker D; Higgins KA
Pretreatment Quality Assurance for Stereotactic Body Radiation Therapy (SBRT): Feasibility of Weekly "SBRT Rounds" in a High-Volume, Multicenter Academic Practice
Volume: 96 Page(s): E546 - E546
10/01/2016 Authors: Parks J; Esiashvili N; Patel PR; Shelton JW; Dhabaan AH; Elder E; Ghavidel S; Whitaker D; Higgins KA
Pretreatment Quality Assurance for Stereotactic Body Radiation Therapy (SBRT): Feasibility of Weekly "SBRT Rounds" in a High-Volume, Multicenter Academic Practice.
Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E546
10/01/2016 Authors: Parks J; Esiashvili N; Patel PR; Shelton JW; Dhabaan AH; Elder E; Ghavidel S; Whitaker D; Higgins KA
Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial.
Int J Radiat Oncol Biol Phys Volume: 96 Page(s): 206 - 213
09/01/2016 Authors: Schreibmann E; Schuster DM; Rossi PJ; Shelton J; Cooper S; Jani AB
Anatomic structure-based deformable image registration of brachytherapy implants in the treatment of locally advanced cervix cancer.
Brachytherapy Volume: 15 Page(s): 584 - 592
01/01/2016 Authors: Ryckman JM; Shelton JW; Waller AF; Schreibmann E; Latifi K; Diaz R
Impact of Anti-3-[18F]FACBC Positron Emission Tomography on Target Volume Definition After Prostatectomy: Initial Findings From a Randomized Trial
Volume: 93 Page(s): S135 - S135
11/01/2015 Authors: Jani A; Schreibmann E; Rossi PJ; Shelton JW; Godette KD; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R
Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC Positron Emission Tomography: Workflow and Initial Findings
Volume: 93 Page(s): E554 - E554
11/01/2015 Authors: Schreibmann E; Schuster DM; Rossi PJ; Shelton JW; Cooper S; Goodman M; Halkar R; Funmilayo T; Odewole O; Jani A
Radiotherapy patterns of care in gastric adenocarcinoma: a single institution experience.
J Gastrointest Oncol Volume: 6 Page(s): 247 - 253
06/01/2015 Authors: Cheng J; Squires MH; Mikell JL; Fisher SB; Staley CA; Kooby DA; El-Rayes BF; Curran WJ; Hall WA; Colbert LE
Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
Am J Clin Oncol Volume: 37 Page(s): 580 - 584
12/01/2014 Authors: Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW
Comparison of image-guided radiotherapy technologies for prostate cancer.
Am J Clin Oncol Volume: 37 Page(s): 616 - 623
12/01/2014 Authors: Das S; Liu T; Jani AB; Rossi P; Shelton J; Shi Z; Khan MK
Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.
Oncogene Volume: 33 Page(s): 5450 - 5456
11/20/2014 Authors: Hall WA; Petrova AV; Colbert LE; Hardy CW; Fisher SB; Saka B; Shelton JW; Warren MD; Pantazides BG; Gandhi K
Survival Outcomes and the Role of Adjuvant Therapy Sequencing in Type II Uterine Cancer After Definitive Surgery
Volume: 90 Page(s): S500 - S500
09/01/2014 Authors: Heumann TR; Diaz R; Liu Y; Hanley K; Horowitz IR; Khanna N; Read W; Shelton JW
A Phase 1 Study Examining a Stereotactic Boost in Combination With Chemoradiation for Patients With Stage III Non-Small Cell Lung Cancer
Volume: 90 Page(s): S626 - S627
09/01/2014 Authors: Higgins KA; Shelton JW; Landry JC; Beitler JJ; Curran WJ
Radiation Therapy Patterns of Care in Gastric Adenocarcinoma: A Single-Institution Experience
Volume: 90 Page(s): S352 - S352
09/01/2014 Authors: Cheng J; Squires MH; Mikell JL; Fisher SB; Hall WA; Colbert LE; Shelton JW; Staley CA; Kooby DA; El-Reyes BF
CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer.
Cancer Res Volume: 74 Page(s): 2677 - 2687
05/15/2014 Authors: Colbert LE; Petrova AV; Fisher SB; Pantazides BG; Madden MZ; Hardy CW; Warren MD; Pan Y; Nagaraju GP; Liu EA
3D Ultrasound Nakagami Imaging for Radiation-Induced Vaginal Fibrosis.
Volume: 9040
02/01/2014 Authors: Yang X; Rossi P; Shelton J; Bruner D; Tridandapani S; Liu T
Pronecrotic Mixed Lineage Kinase Domain-Like (MLKL) Protein Expression Is a Prognostic Biomarker in Patients With Resected Pancreatic Adenocarcinoma
Volume: 87 Page(s): S186 - S187
10/01/2013 Authors: Colbert L; Fisher SB; Hardy CW; Hall WA; Saka B; Adsay NV; Landry JC; Shelton JW; Maithel SK; Yu DS
Multiparametric Ultrasound Imaging of Vaginal Fibrosis Following Radiation Therapy for GYN Malignancies
Volume: 87 Page(s): S427 - S427
10/01/2013 Authors: Yang X; Shelton JW; Rossi P; Bruner DW; Tridandapani S; Liu T
Chromodomain Helicase DNA Binding Protein 5 (CHD5) Is Associated With Improved Overall Survival in Patients Undergoing Adjuvant Therapy for Resected Pancreatic Adenocarcinoma
Volume: 87 Page(s): S665 - S665
10/01/2013 Authors: Hall WA; Hardy CW; Colbert LE; Fisher S; Kooby DA; Adsay V; Shelton J; Maithel S; Landry JC; Yu D
Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.
Cancer Volume: 119 Page(s): 3148 - 3155
09/01/2013 Authors: Colbert LE; Fisher SB; Hardy CW; Hall WA; Saka B; Shelton JW; Petrova AV; Warren MD; Pantazides BG; Gandhi K
In vitro and in vivo enhancement of chemoradiation using the oral PARP inhibitor ABT-888 in colorectal cancer cells.
Int J Radiat Oncol Biol Phys Volume: 86 Page(s): 469 - 476
07/01/2013 Authors: Shelton JW; Waxweiler TV; Landry J; Gao H; Xu Y; Wang L; El-Rayes B; Shu H-KG
A synthetic lethal screen identifies determinants of gemcitabine sensitivity in pancreatic cancer.
Volume: 73
04/15/2013 Authors: Warren MD; Hardy CW; Pantazides BG; Gandhi K; Landry JC; Shelton JW; Maithel SK; El-Rayes B; Kowalski J; Yu DS
Noninvasive evaluation of vaginal fibrosis following radiotherapy for gynecologic malignancies: a feasibility study with ultrasound B-mode and Nakagami parameter imaging.
Med Phys Volume: 40 Page(s): 022901
02/01/2013 Authors: Yang X; Rossi P; Bruner DW; Tridandapani S; Shelton J; Liu T
Clinically Significant Difference in Prostate Localization Using Daily Cone Beam CT (CBCT) and Electromagnetic Transponders.
Pract Radiat Oncol Volume: 3 Page(s): S15
01/01/2013 Authors: Khan MK; Das S; Ogunleye T; Jani AB; Rossi P; Shelton J; Liu T
Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate.
Pract Radiat Oncol Volume: 3 Page(s): e157 - e164
01/01/2013 Authors: Hall WA; Colbert L; Nickleach D; Shelton J; Marcus DM; Switchenko J; Rossi PJ; Godette K; Cooper S; Jani AB
A Synthetic Lethal Screen Identifies Genes That Mediate Gemcitabine Resistance in Pancreatic Cancer
Volume: 84 Page(s): S88 - S88
11/01/2012 Authors: Pantazides B; Hardy C; Gandhi K; Landry J; Shelton J; Maithel S; El-Rayes B; Kowalski J; Yu D
A Loss of Function Genetic Screen Identifies Determinants of Sensitivity to PARP Inhibitor ABT-888 in Pancreatic Cancer
Volume: 84 Page(s): S325 - S325
11/01/2012 Authors: Park W; Pantazides BG; El-Rayes BF; Shelton JW; Yu DS
Efficacy and tolerability of biweekly gemcitabine plus cisplatin (GEMCIS) or gemcitabine plus paclitaxel (GEMPAC) as neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
Volume: 30
05/20/2012 Authors: Karaoglu A; Nieh P; Canter D; Master VA; Carthon B; Harris W; Shelton J; Rossi PJ; Jani AB; Khan MK
A synthetic lethal screen identifies genetic determinants for gemcitabine sensitivity in pancreatic cancer
CANCER RESEARCH Volume: 72
04/15/2012 Authors: Landry JC; Pantazides BG; Park W; Shelton JW; Maithel SK; El-Rayes B; Yu DS
Observations on prostate intrafraction motion and the effect of reduced treatment time using volumetric modulated arc therapy.
Pract Radiat Oncol Volume: 1 Page(s): 243 - 250
01/01/2011 Authors: Shelton J; Rossi PJ; Chen H; Liu Y; Master VA; Jani AB
The role of radio-surgery in patients with metastatic melanoma to the brain
Volume: 28
05/20/2010 Authors: Lowe MC; Cavitt A; Shelton J; Crocker IR; Pan L; Lawson DH; Carlson GW; Delman KA; Rizzo M
Impact of Prostate Motion on Delivered Dose during Intensity Modulated Radiotherapy
Volume: 78 Page(s): S685 - S685
01/01/2010 Authors: Schreibmann E; Shelton J; Rossi PJ; Master VA; Jani AB
Clinically useful observations of prostate motion using the Calypso four-dimensional localization system
Volume: 72 Page(s): S299 - S300
01/01/2008 Authors: Shelton J; Ogunleye T; Jani AB; Elder E; Rossi PJ

Directory section navigation

Profile